What is scary in infection prevention and control? Dr. Popescu tells us what's in the news this week of Halloween.
The author, Saskia v. Popescu, PhD, MPH, MA, CIC.
What’s scary to an infection preventionist? In truly, I always jokingly say that my personal risk tolerance is pretty nutty from years of working infectious diseases and that I tend to hit the panic button around Clostridioides difficile more than other things that would worry folks. As we celebrated Halloween this week, I’d be curious if your version of “scary” in the work of infection prevention and control (IPC) has changed over the years? What about since COVID-19? Ebola is likely on the list for most of us, though. (Email Infection Control Today® and let us know!)
Ebola Outbreak
Unfortunately, Uganda has reported 2 more Ebola Sudan cases and 9 more deaths, which now means this outbreak has reached 130 cases and 43 deaths. “At a World Health Organization (WHO) briefing today, Director-General Tedros Adhanom Ghebreyesus, PhD, said Mubende is still the most affected district, but cases have recently risen in two neighboring districts. He said that, so far, 17 cases have been confirmed in Kampala, the country's capital and largest city. He also added that the WHO yesterday released an additional $5.7 million from its emergency contingency fund to further support the response.” Efforts are ongoing to perform contact tracing and control the spread of the outbreak. Given these numbers, it would be helpful to share with emergency department and urgent care personnel about travel-related exposures and to ask those important questions. Remember, in 2014 we didn’t think Ebola wouldn’t happen in the United States…until it did.
COVID-19: Are We Starting to See an Increase in Cases?
From October 29th until early November, we’ve started to see a slight increase in cases of COVID-19 within the United States. Ever so small, but a 2% increase in cases in the last two weeks. This is also mirrored in hospitalizations.If we look at what’s happening across the country, some places are seeing a more substantial increase in cases. Missouri has a 67% increase in cases in the last two weeks, while New Mexico has a 53% spike, Arizona has 101%, and Nevada has a 92% increase in cases as well. It’s early still, but those numbers are already starting to worry many. With respiratory syncytial virus (RSV) numbers causing a spike in pediatric cases and hospitalizations, and flu on the rise, it’s not surprising that these numbers are something we should keep an eye on in healthcare readiness and infection prevention. Pandemic fatigue is real, but we all know how severe the winters can be, so now is the time to check on personal protection equipment (PPE) levels, make sure those isolation signs are available, and folks are aware of what surges in influenza and RSV are like after several years of (mostly) COVID-19.
A few tidbits that you may find interesting…
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.